Journal of Cancer Research and Therapeutics Close
 

Figure 1: (a) Pleomorphic malignant cells showing hyperchromatic nuclei, prominent nucleoli, intranuclear inclusions, and abundant eosinophilic cytoplasm. (b) Immunohistochemistry showing malignant cells immunoreactive for HMB-45. (c) Immunoreactive for S-100. (d) Immunoreactive for melan A

Figure 1: (a) Pleomorphic malignant cells showing hyperchromatic nuclei, prominent nucleoli, intranuclear inclusions, and abundant eosinophilic cytoplasm. (b) Immunohistochemistry showing malignant cells immunoreactive for HMB-45. (c) Immunoreactive for S-100. (d) Immunoreactive for melan A